Safety and Efficacy of Etanercept in Patients With Psoriasis

NCT02258282 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

80

Enrollment

OTHER

Sponsor class

Conditions

Psoriasis

Interventions

DRUG: Etanercept
DRUG: Control

Sponsor

Chengdu PLA General Hospital